Benzodiazepines

Probably not — and the question deserves a straight answer rather than a lecture. If you take the drug as prescribed, at a stable dose, and it helps, what you most likely have is physiological dependence: your body has adapted to the drug, so stopping suddenly would cause withdrawal. That is an expected pharmacological consequence of regular use, not a behaviour and not a character flaw. Addiction — a substance-use disorder — is different: it means compulsive use, loss of control, craving, escalating doses you weren't prescribed, use that continues despite it harming your life. Most long-term benzodiazepine patients are dependent and not addicted, and the national data reflect that: of the 30.6 million US adults using benzodiazepines in a year, 25.3 million used them as prescribed. This distinction is not a technicality. People who are told that dependence means addiction often stop abruptly out of alarm, and abrupt stopping is the single most dangerous thing you can do with this drug. If you want to come off, that is a legitimate goal and a conversation with your prescriber — planned, gradual, supported. It is not something to do this week because a page frightened you.

We don't know, and anyone who tells you confidently either way is going beyond the evidence. Here is the actual state of it. A large case-control study found benzodiazepine use associated with Alzheimer's disease — odds ratio around 1.5 — with the association getting stronger at higher cumulative doses, which normally suggests a real drug effect. But a prospective study following people over more than seven years found the opposite pattern: a small increase at the LOWEST exposure and no increase at the highest, no faster cognitive decline with more use, and the authors concluded their results did not support a causal association. That inversion is the whole argument. If a drug caused dementia, more drug should mean more dementia; a signal that shows up at minimal use and disappears at heavy use looks like something else — most plausibly that anxiety, agitation and broken sleep are early symptoms of dementia, so the developing disease leads to the prescription rather than the other way round. So: the association is real and has been found more than once; whether benzodiazepines cause dementia is genuinely unresolved, and the best prospective evidence argues against. What is better established, and separate, is that they impair memory and concentration while you are taking them — that effect is real, and is a good reason to review long-term use on its own merits.

Stopping suddenly after regular use can be genuinely dangerous — this is one of the few drug classes where that is true, and it is the most important safety message on this page. Because benzodiazepines enhance the brain's main inhibitory signal, removing them abruptly leaves a brain that is hyperexcitable, and the withdrawal syndrome can include seizures and delirium as well as severe anxiety, insomnia, tremor and sweating. It can be fatal. That is not a reason to stay on them forever; it is a reason that coming off is a planned, gradual, individualised process done with your prescriber rather than a decision made alone on a Sunday. BioSignal deliberately does not publish a taper schedule. That is not us withholding something useful — the right rate genuinely differs between people, a schedule that suits one person can be unsafe for another, and the evidence itself is thin: a Cochrane review of pharmacological approaches to discontinuation found the evidence too weak and inconsistent to recommend any specific strategy. If you want to stop, the correct next step is to ask your prescriber for a plan built around you. If you have already stopped abruptly and feel unwell — especially with confusion, hallucinations, or any seizure — seek urgent medical care.

Mixing them, by a wide margin. On their own, benzodiazepines have a relatively wide safety margin and are difficult to fatally overdose on — that is a genuine pharmacological fact, and part of why they replaced barbiturates. The danger is what they are combined with. Benzodiazepines and opioids both suppress breathing, and together the risk multiplies: among people taking opioids, also taking a benzodiazepine was associated with roughly double the odds of ending up in an emergency room or hospital for an opioid overdose. Alcohol works through a similar mechanism and adds the same way. This is the reason for the FDA's boxed warning about combining benzodiazepines with opioids, and it is the specific thing to be careful about — including with alcohol you would otherwise think nothing of. After combination, the harms that matter most are falls and fractures (particularly in older adults), and driving: benzodiazepines impair reaction time and judgement in ways people consistently underestimate, including the morning after a night-time dose.

This is the population where the balance shifts most clearly against them. The American Geriatrics Society Beers Criteria — the standard reference for potentially inappropriate prescribing in older people — list benzodiazepines as drugs to avoid in adults 65 and over, principally because of falls, fractures and cognitive impairment, and specifically advise against using them for insomnia, agitation or delirium. Older bodies clear the drugs more slowly, so effects last longer and accumulate, and a fall that would be minor at 40 can be life-changing at 80. There is a paradox worth knowing here too: benzodiazepines sometimes cause agitation and confusion in older adults rather than settling it, which occasionally leads to more of the drug being given for a problem the drug is causing. None of this is a reason for an older person currently taking one to stop abruptly — that carries its own serious risk. It is a strong reason for the prescription to be reviewed, and for alternatives to be considered where they exist.

More often than the current conversation suggests, in defined situations. In alcohol withdrawal they are first-line and prevent withdrawal seizures — a Cochrane review found them protective against seizures compared with placebo, which makes this a life-saving use rather than a comfort measure. For prolonged seizures and status epilepticus they are a standard emergency treatment. For acute, severe panic or agitation they work within minutes, which nothing else useful does. For procedural sedation they are routine and appropriate. Short courses at points of acute crisis can be entirely reasonable. What the evidence does not support is the open-ended daily prescription for chronic anxiety or insomnia that became common — that is where tolerance, dependence and accumulating harm live, and where better long-term options exist. The useful frame is not 'good drug or bad drug' but 'right job or wrong job': a fast, powerful, short-term tool that was widely used as a long-term one.